返回
Mapping CAR T-Cell Design Space Using Agent-Based Models
DOI:10.3389/fmolb.2022.849363.png)
摘要
En 中文
Chimeric antigen receptor (CAR) T-cell therapy shows promise for treating liquid cancers and increasingly for solid tumors as well. While potential design strategies exist to address translational challenges, including the lack of unique tumor antigens and the presence of an immunosuppressive tumor microenvironment, testing all possible design choices in vitro and in vivo is prohibitively expensive, time consuming, and laborious. To address this gap, we extended the modeling framework ARCADE (Agent-based Representation of Cells And Dynamic Environments) to include CAR T-cell agents (CAR T-cell ARCADE, or CARCADE). We conducted in silico experiments to investigate how clinically relevant design choices and inherent tumor features-CAR T-cell dose, CD4(+):CD8(+) CAR T-cell ratio, CAR-antigen affinity, cancer and healthy cell antigen expression-individually and collectively impact treatment outcomes. Our analysis revealed that tuning CAR affinity modulates IL-2 production by balancing CAR T-cell proliferation and effector function. It also identified a novel multi-feature tuned treatment strategy for balancing selectivity and efficacy and provided insights into how spatial effects can impact relative treatment performance in different contexts. CARCADE facilitates deeper biological understanding of treatment design and could ultimately enable identification of promising treatment strategies to accelerate solid tumor CAR T-cell design-build-test cycles.
Keyword:
agent-based model
CAR T-cell
simulation
cell population dynamics
model-guided design
emergent dynamics
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
4
论文数:
6.0K
被引数:
2.0W
机构
引用论文
Resource allocation in cellular networks employing mobile femtocells with deterministic mobility采用具有确定性移动性的移动毫微微小区的蜂窝网络中的资源分配
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells共受体的不同信号调节特定的代谢途径并影响CAR T细胞的记忆发展
IMMUNITY
IF26.3
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivoCar-t细胞靶向递送PD-1-blocking scFv增强体内抗肿瘤功效
NATURE BIOTECHNOLOGY
IF41.7
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
CANCER RESEARCH
IF16.6

